Examining the effects of false positive lung cancer screening results on subsequent lung cancer screening adherence

Cancer Epidemiology Biomarkers and Prevention

Volumn 12, Issue 1, 2003, Pages 28-33

  Ford, Marvella E ^a   Havstad, Suzanne L ^a   Flickinger, Lynn ^a   Johnson, Christine Cole ^a  

^a HENRY FORD HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; CLINICAL PRACTICE; CONTROLLED STUDY; EDUCATION; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEGRO; PREDICTION; PRIORITY JOURNAL; SAMPLE SIZE; SEX DIFFERENCE; SMOKING; THORAX RADIOGRAPHY;

FALSE POSITIVE REACTIONS; FEMALE; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MASS CHEST X-RAY; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE; RISK FACTORS; SMOKING;

EID: 0037243663     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Prorok, P. C., Andriole, G. L., Bresalier, R. S., Buys, S. S., Chia, D., Crawford, E. D., Fogel, R., Gelmann, E. P., Gilbert, F., Hasson, M. A., Hayes, R. B., Johnson, C. C., Mandel, J. S., Oberman, A., O'Brien, B., Oken, M. M., Rafla, S., Reding, D., Rutt, W., Weissfeld, J. L., Yokochi, L., and Gohagen, J. K. PLCO Project Team. Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control. Clin. Trials, 21: 273S-309S, 2000.
2. Gohagan, J. K., Prorok, P. C., Hayes, R. B., and Kramer, B. S. PLCO Project Team. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer screening trial of the national cancer institute: history, organization, and status. Control. Clin. Trials, 21: 251S-272S, 2000.
3. Simpson, N. K., Johnson, C. C., Ogden, S. L., Gamito, E., Trocky, N., McGuire, C., Martin, J., Barrow, S., Lamerato, L., Flickinger, L. M., Broski, K., Englehard, D., Hilke, C., Bonk, J., Gahagan, B., Gren, L. H., Childs, J., Lappe, K., Fouad, M., Thompson, J., and Sullivan, D. PLCO Project Team. Recruitment strategies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial: the first six years. Control. Clin. Trials, 6S: 356S-378S, 2000.
4. Stallings, F. L., Ford, M. E., Simpson, N. K., Fouad, M., Jernigan, J. C., Trauth, J., and Miller, D. S. Black participation in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control. Clin. Trials, 21: 379S-389S, 2000,
5. Collins, M. M., and Barry, M. J. Controversies in prostate cancer screening: analogies to the early lung. JAMA, 276: 1976-1979, 1996.
6. Barton, M. B., Moore, S., Polk, S., Shtatland, E., Elmore, J., and Fletcher, S. W., Increased patient concern after false-positive mammograms: clinician documentation and subsequent ambulatory visits. J. Gen. Intern. Med., 16: 150-156, 2001.
7. Lipkus, I. M., Halabi, S., Strigo, T. S., and Rimer, B. K. The impact of abnormal mammograms on psychosocial outcomes and subsequent screening. Psycho-Oncology, 9: 402-410, 2000.
8. Gram, I. T., Lund, E., and Slenker, S. E. Quality of life following a false positive mammogram. Br. J. Cancer, 62: 1018-1022, 1990.
9. Padgett, D. K., Yedidia, M. J., Kerner, J., and Mandelblatt, J. The emotional consequences of false positive mammography: African-American women's reactions in their own words. Women Health, 33: 1-14, 2001.
10. Aro, A. R., Absetz, S. P., van Elderen, T. M., van der Ploeg, E., and van der Kamp, L. J. T. False-positive findings in mammography screening induces short-term distress-breast cancer-specific concern prevails longer. Eur. J. Cancer, 36: 1089-1097, 2000.
11. Pisano, E. D., Earp, J. A., and Gallant, T. L. Screening mammography behavior after a false positive mammogram. Radiology, 208: 245-249, 1998.
12. Burman, M. L., Taplin, S. H., Herta, D. F., and Elmore, J. G. Effect of false-positive mammograms on interval breast cancer screening in a health maintenance organization. Ann. Intern. Med., 131: 1-6, 1999.
13. Lerman, C., Trock, B., Rimer, B. K., Boyce, A., Jepson, C., and Engstrom, P. F. Psychological and behavioral implications of abnormal mammograms. Ann. Intern. Med., 114: 657-661, 1991.
14. Becker, M. H., and Maiman, L. A. Sociobehavioral determinants of compliance with health care and medical care recommendations. Medical Care, 13: 10-24, 1975.
15. Jones, S. L., Jones, P. K., and Katz, J. Compliance in acute and chronic patients receiving a Health Belief Model intervention in the emergency department. Soc. Sci. Med., 32: 1183-1189, 1991.
16. Barroso, J., McMillian, S., Casey, L., Gibson, W., Kaminskin, G., and Meyer, J. Comparison between African-American and white women in their beliefs about breast cancer and their health locus of control. Cancer Nurs., 23: 268-276, 2000.
17. Paskett, E. D., Carter, W. B., Chu, J., and White, E. Compliance behavior in women with abnormal pap smears: developing and testing a decision model. Med. Care, 28: 643-656, 1990.
18. Lam, S., Lam, B., and Petty, T. L. Early detection for lung cancer: new tools for casefinding. Can. Fam. Physician, 47: 537-544, 2001.